Novolog (Pharm-Up 1966) Ltd

Informe acción TASE:NVLG

Capitalización de mercado: ₪801.8m

Novolog (Pharm-Up 1966) Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Aviad Bossi

Chief Executive Officer (CEO)

₪1.8m

Compensación total

Porcentaje del salario del CEO42.3%
Permanencia del CEO1.3yrs
Participación del CEOn/a
Permanencia media de la dirección3.7yrs
Promedio de permanencia en la Junta Directiva7.2yrs

Actualizaciones recientes de la dirección

How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

Dec 29
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

Recent updates

Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Nov 05
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital

Jul 25
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital

I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease

May 07
I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease

Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend

Apr 14
Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend

Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality

Mar 24
Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality

Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 09
Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?

Feb 15
How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own?

Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years

Jan 25
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years

How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

Dec 29
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid?

With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting

Dec 08
With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Aviad Bossi en comparación con los beneficios de Novolog (Pharm-Up 1966)?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-₪18m

Mar 31 2024n/an/a

-₪20m

Dec 31 2023₪2m₪762k

-₪42m

Compensación vs. Mercado: La compensación total ($USD480.56K) de Aviad está en línea con el promedio de empresas de tamaño similar en el mercado IL ($USD630.83K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Aviad con los resultados de la empresa.


CEO

Aviad Bossi (48 yo)

1.3yrs

Permanencia

₪1,802,000

Compensación

Mr. Aviad Bossi is Chief Executive Officer of Novolog (Pharm-Up 1966) Ltd from July 01, 2023.


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Aviad Bossi
Chief Executive Officer1.3yrs₪1.80msin datos
Nega Hon
Vice President of Information Systems1.9yrs₪1.08msin datos
Assi Weshler
Chief Executive Officer of Trilog & Medicare to Homeno data₪2.33msin datos
Yehiel Asia
Chief Executive Officer of Ein Talno data₪1.25msin datos
Rafi Friedman
Chief Executive Officer of Mediplast Israel Ltd.6.8yrs₪1.19msin datos
Yaniv Vidavsky
Chief Financial Officerless than a yearsin datossin datos
Adi Marx
Vice President of Business Development & Special Projects1.8yrssin datossin datos
Gali Srogati
Vice President of Human Resourcesless than a yearsin datossin datos
David Shmuelov
Chief Executive Officer of Drug Distribution & Medical Device Company5.5yrssin datossin datos
Amitai Gridish
Chief Executive Officer of Target Care Services Ltd.5.5yrssin datossin datos
Ofer Amar
Chief Executive Officer of Mediquip Ltd.7.1yrs₪2.03msin datos
Avir Dor
Chief Executive Officer of Generation Pharmaceuticals Ltd.13.5yrssin datossin datos

3.7yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NVLG se considera experimentado (3.7 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Tamar Gottlieb
Independent Non-Executive Director2yrssin datossin datos
David Ben-Ami
Independent External Director7.5yrssin datossin datos
Miriam Shave
Independent External Director7.5yrssin datossin datos
Itay Taleh
Director8.3yrssin datossin datos
Demi Dor
Chairman of the Board6.9yrs₪293.00ksin datos
Varda Shalev
Director1.9yrssin datossin datos

7.2yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de NVLG se considera experimentada (7.2 años de antigüedad promedio).